tRNA synthetase, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | yes | yes: 3 |
Silverman et al. | no | yes: 3 |
Pissara et al. | yes | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HZS5
Term | Name | Level | Count |
---|---|---|---|
GO:0000049 | tRNA binding | 5 | 11 |
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003824 | catalytic activity | 1 | 3 |
GO:0004812 | aminoacyl-tRNA ligase activity | 4 | 3 |
GO:0016874 | ligase activity | 2 | 3 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3 | 3 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 3 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 3 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 248 | 252 | PF00656 | 0.565 |
CLV_C14_Caspase3-7 | 383 | 387 | PF00656 | 0.540 |
CLV_MEL_PAP_1 | 255 | 261 | PF00089 | 0.385 |
CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.581 |
CLV_NRD_NRD_1 | 266 | 268 | PF00675 | 0.384 |
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.608 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.583 |
CLV_PCSK_KEX2_1 | 266 | 268 | PF00082 | 0.363 |
CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.380 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.639 |
CLV_PCSK_PC1ET2_1 | 330 | 332 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 243 | 247 | PF00082 | 0.810 |
CLV_PCSK_SKI1_1 | 349 | 353 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.551 |
CLV_Separin_Metazoa | 207 | 211 | PF03568 | 0.592 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.522 |
DOC_ANK_TNKS_1 | 38 | 45 | PF00023 | 0.492 |
DOC_MAPK_gen_1 | 313 | 320 | PF00069 | 0.606 |
DOC_MAPK_gen_1 | 330 | 337 | PF00069 | 0.508 |
DOC_MAPK_RevD_3 | 196 | 212 | PF00069 | 0.639 |
DOC_PP1_RVXF_1 | 347 | 353 | PF00149 | 0.567 |
DOC_PP2B_LxvP_1 | 23 | 26 | PF13499 | 0.562 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.599 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.595 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.557 |
DOC_USP7_MATH_1 | 196 | 200 | PF00917 | 0.696 |
DOC_USP7_MATH_1 | 229 | 233 | PF00917 | 0.624 |
DOC_USP7_UBL2_3 | 215 | 219 | PF12436 | 0.568 |
DOC_USP7_UBL2_3 | 243 | 247 | PF12436 | 0.758 |
DOC_WW_Pin1_4 | 231 | 236 | PF00397 | 0.737 |
DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.616 |
LIG_14-3-3_CanoR_1 | 133 | 137 | PF00244 | 0.476 |
LIG_14-3-3_CanoR_1 | 39 | 43 | PF00244 | 0.559 |
LIG_14-3-3_CanoR_1 | 58 | 64 | PF00244 | 0.464 |
LIG_Actin_WH2_2 | 43 | 60 | PF00022 | 0.553 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.569 |
LIG_FHA_1 | 283 | 289 | PF00498 | 0.559 |
LIG_FHA_1 | 302 | 308 | PF00498 | 0.563 |
LIG_FHA_1 | 373 | 379 | PF00498 | 0.475 |
LIG_FHA_2 | 127 | 133 | PF00498 | 0.517 |
LIG_FHA_2 | 192 | 198 | PF00498 | 0.659 |
LIG_FHA_2 | 246 | 252 | PF00498 | 0.638 |
LIG_FHA_2 | 381 | 387 | PF00498 | 0.478 |
LIG_KLC1_Yacidic_2 | 272 | 277 | PF13176 | 0.563 |
LIG_LIR_Apic_2 | 168 | 173 | PF02991 | 0.498 |
LIG_LIR_Apic_2 | 197 | 203 | PF02991 | 0.765 |
LIG_LIR_LC3C_4 | 304 | 309 | PF02991 | 0.612 |
LIG_LIR_Nem_3 | 46 | 50 | PF02991 | 0.573 |
LIG_PCNA_PIPBox_1 | 374 | 383 | PF02747 | 0.499 |
LIG_SH2_NCK_1 | 110 | 114 | PF00017 | 0.600 |
LIG_SH2_NCK_1 | 142 | 146 | PF00017 | 0.538 |
LIG_SH2_PTP2 | 200 | 203 | PF00017 | 0.735 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.538 |
LIG_SH2_STAP1 | 356 | 360 | PF00017 | 0.602 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.574 |
LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.735 |
LIG_SH2_STAT5 | 275 | 278 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 296 | 299 | PF00017 | 0.558 |
LIG_SH3_3 | 95 | 101 | PF00018 | 0.587 |
LIG_SUMO_SIM_anti_2 | 72 | 81 | PF11976 | 0.598 |
LIG_TRAF2_1 | 203 | 206 | PF00917 | 0.600 |
MOD_CAAXbox | 412 | 415 | PF01239 | 0.560 |
MOD_CDK_SPxxK_3 | 231 | 238 | PF00069 | 0.763 |
MOD_CDK_SPxxK_3 | 60 | 67 | PF00069 | 0.614 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.622 |
MOD_CK1_1 | 21 | 27 | PF00069 | 0.534 |
MOD_CK2_1 | 108 | 114 | PF00069 | 0.618 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.340 |
MOD_CK2_1 | 191 | 197 | PF00069 | 0.845 |
MOD_CK2_1 | 201 | 207 | PF00069 | 0.542 |
MOD_Cter_Amidation | 241 | 244 | PF01082 | 0.821 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.522 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.568 |
MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.730 |
MOD_GlcNHglycan | 231 | 234 | PF01048 | 0.724 |
MOD_GlcNHglycan | 235 | 238 | PF01048 | 0.776 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.332 |
MOD_GlcNHglycan | 369 | 372 | PF01048 | 0.474 |
MOD_GlcNHglycan | 399 | 402 | PF01048 | 0.649 |
MOD_GSK3_1 | 118 | 125 | PF00069 | 0.624 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.449 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.571 |
MOD_GSK3_1 | 229 | 236 | PF00069 | 0.753 |
MOD_GSK3_1 | 245 | 252 | PF00069 | 0.580 |
MOD_GSK3_1 | 372 | 379 | PF00069 | 0.556 |
MOD_N-GLC_1 | 146 | 151 | PF02516 | 0.554 |
MOD_N-GLC_1 | 183 | 188 | PF02516 | 0.656 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.505 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.562 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.553 |
MOD_NEK2_1 | 250 | 255 | PF00069 | 0.603 |
MOD_NEK2_1 | 301 | 306 | PF00069 | 0.537 |
MOD_NEK2_1 | 318 | 323 | PF00069 | 0.575 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.525 |
MOD_PIKK_1 | 245 | 251 | PF00454 | 0.542 |
MOD_PIKK_1 | 301 | 307 | PF00454 | 0.636 |
MOD_PIKK_1 | 319 | 325 | PF00454 | 0.612 |
MOD_PKA_1 | 243 | 249 | PF00069 | 0.735 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.468 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.558 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.590 |
MOD_PKA_2 | 57 | 63 | PF00069 | 0.298 |
MOD_Plk_1 | 196 | 202 | PF00069 | 0.674 |
MOD_Plk_1 | 250 | 256 | PF00069 | 0.579 |
MOD_Plk_1 | 5 | 11 | PF00069 | 0.500 |
MOD_Plk_2-3 | 132 | 138 | PF00069 | 0.593 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.473 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.784 |
MOD_Plk_4 | 313 | 319 | PF00069 | 0.552 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.528 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.598 |
MOD_ProDKin_1 | 231 | 237 | PF00069 | 0.739 |
MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.611 |
MOD_SUMO_for_1 | 218 | 221 | PF00179 | 0.671 |
MOD_SUMO_rev_2 | 236 | 245 | PF00179 | 0.819 |
MOD_SUMO_rev_2 | 332 | 338 | PF00179 | 0.580 |
TRG_DiLeu_BaEn_1 | 75 | 80 | PF01217 | 0.582 |
TRG_DiLeu_BaEn_2 | 64 | 70 | PF01217 | 0.605 |
TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.570 |
TRG_ER_diArg_1 | 209 | 212 | PF00400 | 0.581 |
TRG_ER_diArg_1 | 265 | 267 | PF00400 | 0.584 |
TRG_ER_diArg_1 | 57 | 59 | PF00400 | 0.617 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P301 | Leptomonas seymouri | 66% | 98% |
A0A0S4IJF4 | Bodo saltans | 39% | 99% |
A0A1X0NUW2 | Trypanosomatidae | 45% | 100% |
A0A3R7KNR3 | Trypanosoma rangeli | 44% | 100% |
A0A3S7WX09 | Leishmania donovani | 100% | 100% |
A4HC93 | Leishmania braziliensis | 77% | 100% |
C9ZRK5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 98% |
E9AVN0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4QBU9 | Leishmania major | 86% | 100% |